Stakeholders seek clarity, risk-based approach in AI/ML PCCP guidance
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy